Abstract 27
Active pharmaceutical ingredients (APIs) have raised considerable concern over the 28 last decade due to their widespread detection in water resources and their potential to 29 affect ecosystem health. This triggered many attempts to prioritize the large number 30 of known APIs to target monitoring efforts and testing of fate and effects. However, 31 so far, a comprehensive approach to screen for their presence in surface waters has 32 been missing. Here, we explore a combination of an automated suspect screening 33 approach based on liquid chromatography coupled to high-resolution mass 34 spectrometry and a model-based prioritization using consumption data, readily 35 predictable fate properties and a generic mass balance model for activated sludge 36 treatment to comprehensively detect APIs with relevant exposure in wastewater 37 treatment plant effluents. The procedure afforded the detection of 27 APIs that had 38 not been covered in our previous target method, which included 119 parent APIs. The 39 newly detected APIs included seven compounds with a high potential for 40 bioaccumulation and persistence, and also three compounds that were suspected to 41 stem from point sources rather than from consumption as medicines. Analytical 42 suspect screening proved to be more selective than model-based prioritization, 43 making it the method of choice for focusing analytical method development or fate 44 and effect testing on those APIs most relevant to the aquatic environment. However, 45
we found that state-of-the-practice exposure modeling used to predict potential high-46 exposure substances can be a useful complement to point towards oversights and 47
Introduction 52
Active pharmaceutical ingredients (APIs), i.e., the pharmaceutically active chemicals 53 contained in human and veterinary medicines, have been an emerging issue in 54 environmental chemistry and (eco-)toxicology for the last 15 years [1] [2] [3] . Advances in 55 analytical chemistry, most importantly the coupling of liquid chromatography to 56 electrospray-ionization-based mass spectrometry (LC-ESI-MS), enabling detection 57 and quantification of polar compounds at concentrations in the low ng/L range, has 58 raised the awareness that their release in treated wastewater leads to the continuous 59 presence of mixtures of tens to hundreds of APIs in surface waters across the globe. 60
These mixtures have been shown to not only pose a risk to aquatic organisms through 61 various specific and non-specific effects 4 , but also to impact the quality of food crops 62 and drinking water through irrigation and groundwater recharge, respectively [5] [6] [7] [8] . 63
As a consequence, several research projects on the subject of APIs were initiated, 64 including several EU projects (e.g., Poseidon, Repharmawater, Neptune, ERAPharm, 65
Reclaim Water, Pharmas, Cytothreat). An integral part of many of these research 66 endeavors was extensive monitoring of APIs to establish their presence and to 67 understand their temporal and spatial patterns in different water resources. For this 68 purpose, multi-component analytical methods based on liquid chromatography 69 tandem mass spectrometry (LC-MSMS) and increasingly also on high-resolution 70 mass spectrometry (LC-HRMS) have been developed in various analytical chemistry 71 laboratories for quantification of some dozens up to more than 100 targeted APIs in 72 one analytical method (e.g., [9] [10] [11] [12] [13] ). However, since even with the most advanced 73 analytical methods, the expense for monitoring is high, lists of target APIs underlying 74 these methods need to be compiled by prioritizing those APIs considered most 75 relevant for the question at hand. 76 Different criteria for establishing such priority lists have been applied using a range of 77 prioritization approaches 14, 15 from qualitative ranking based on one or several 78 ranking criteria (e.g., [16] [17] [18] [19] ), over more quantitative multicriteria methods (e.g., 20, 21 ) 79 all the way to estimating risk quotients (e.g., 16, [22] [23] [24] [25] ). The most often used criteria 80 include: consumption data, estimates of removal during wastewater treatment and 81 treatability in drinking water production, hazard indicators such as PBT criteria 18, 25, 
82
26 , (eco-)toxicity data and adverse outcome pathway information 15, 19, 25, 27, 28 , 83 similarity to known APIs of environmental concern 29, 30 , and previous measurements. 84
While certainly successful in capturing the majority of the most prevalent APIs, such 85
In this study, we therefore explored whether the combination of the rather novel 119 approach of automated LC-HRMS-based suspect screening with the established 120 approach of model-based prioritization would allow for a rapid and more 121 comprehensive detection of APIs with relevant exposure in surface waters than any of 122 the two methods separately. To test this hypothesis, we defined the following study 123 objectives: (i) Exact mass screening of treated wastewaters based on a comprehensive 124 list of suspect API masses to detect as many APIs as possible; (ii) exposure prediction 125 using state-of-the-practice approaches to prioritize the list of suspect APIs in terms of 126 expected concentrations in WWTP effluents; and (iii) assessment of the 127 complementarity of both approaches to effectively detect new APIs not commonly 128 included in current target lists. The simultaneous application of exposure modeling 129 and suspect screening enables an evaluation of the sensitivity and selectivity of both 130 methodologies while highlighting their strengths and weaknesses. 131
132

Materials and Methods 133
Mass list and consumption data 134
To come up with a screening list, available consumption data from Switzerland (IMS 135 
LC-HRMS/MS 180
20 µL of each sample extract was injected and separated on a XBridge C18 column 181 (3.5 µm, 2.1 x 50 mm; Waters, Ireland) equipped with a 2.1 × 10 mm precolumn of 182 the same material. The gradient (water/methanol, both with 0.1% formic acid) was 183 run as described in Table S1 . The HPLC system consisted of a PAL autosampler 184 (CTC Analytics, Zwingen, Switzerland) and a Rheos 2200 HPLC pump (Flux 185
Instruments, Basel, Switzerland). respective metabolites and were used for quantification purposes (see Table S3 ). The After removal of the detected target peaks (monoisotopic and isotopic masses) from 231 the resulting peak lists, the remaining positive hits for the list of suspect APIs 232 (negative and positive ionization mode) were prioritized for further analysis as 233 described in detail by Moschet et al. 34 . Prioritization was performed by applying 234 filters for peak intensity, blank subtraction, peak symmetry and isotope pattern. and ≥ 10 6 in negative and positive mode, respectively, or suspects in any one sample 241 with peak intensity ≥ 10 7 and ≥ 10 8 for negative and positive mode, respectively, were 242 selected for further processing. The latter criterion was introduced to also account for 243 substances occurring only randomly at very high concentrations. Second, peaks also 244 present in the method blank were deselected (retention time: ± 1 min, m/z: ± 5 ppm). 245
Third, symmetry and width of suspect peaks were inspected and peaks were excluded 246 if chromatographic width exceeded 1 min or that showed asymmetric peak shape 247 (IUPAC tailing factor of <0.5 at 10% peak height). Finally, an isotope pattern check 248 was manually conducted for the remaining suspects with a tolerance for isotope 249 abundances and mass accuracy of 20 % and 5 ppm, respectively. Xcalibur Qual 250
Browser (Thermo Fisher Scientific Corp., USA) was used for manual peak 251 inspections. For suspects that passed all filtering steps, authentic reference standards 252
were purchased for confirmation. 253
For confirmed suspects, concentrations in the WWTP samples were retrospectively 254 quantified. For this purpose, calibration series with reference standards for the 255 suspects in nanopure water were produced using the described SPE procedure. The 256 ILIS mix was spiked before SPE and the method of internal calibration was applied 257 using for each confirmed suspect the ILIS with the closest retention time. 
Swiss consumption data was used wherever available (n=140) (P = 7,785,800), and 269 for the other compounds consumption data from Germany (P = 81,882,000), France 270 (P = 60,424,213) or the US (P = 282,082,000) were used in order of decreasing 271 preference. Excretion was estimated based on information given in the Swiss database 272 on human pharmaceuticals 48 , in two medical databases (drugs.com, drugbank.com), 273 and in a compilation by Lienert et al. 49 . In total, excretion rates of 368 suspect APIs 274 were available. It was assumed that APIs excreted in feces and urine would both enter 275 biological treatment and that glucuronide conjugates would be fully deconjugated 276 during biological treatment. Consequently, all these fractions were summed up for 277 estimating the fraction excreted. For the remainder of compounds for which excretion 278 data were not available, a worst-case default value of 100% excretion was assumed. 279
Removal during wastewater treatment was estimated using the STPWIN model from 280 EPI Suite 50 (for more information on STPWIN see SI-5). 281
The validity of using model-based exposure predictions for prioritization of APIs was 282 evaluated in two ways: First, the accuracy of predictions was assessed by comparing 283 PEC predictions for the target compounds to measured concentrations in WWTPs A-284 E (WWTP F was excluded from this comparison because its effluent was strongly 285 diluted with industrial wastewater and the wastewater composition was therefore not 286 considered to be representative of a typical municipal wastewater, see results). 287
Second, the ability to correctly prioritize substances with high exposure potential was 288 evaluated by comparing the subset of compounds predicted to be present in high 289 concentrations (PEC > 1 ug/L) against detected suspect and target compounds. were subjected to the prioritization and confirmation workflow as described in the 304 method section. 305
In Figure 1 , the numbers of targets detected (APIs and metabolites) and their 306 concentration are presented for the individual WWTP samples, and, in Table S3 of concentrations. This observation may point towards superior performance of 325 nitrifying/denitrifying plants (WWTPs A-C) in removing micropollutants, as has been 326 found before 51, 52 . The effluent from WWTP F exhibits the lowest number of APIs, 327 which could be explained by the dilution of the domestic wastewater with large shares 328 of industrial wastewater (Table 1) , but might also be due to higher limits of detection 329 in this specific wastewater matrix, which have not been determined separately. 330
Ten of our 119 parent target APIs were on the list of high-production volume 331 pharmaceuticals which Howard and Muir 26 estimated to be persistent and in some 332 cases also bioaccumulative. Eight of those were detected in our study 333 (levomethadone/methadone, irbesartan, metoclopramide, bupropion/wellbutrin, 334 lamotrigine/lamictal, fluconazole, rosuvastatin/crestor, bicalutamide), whereas the 335 remaining two (losartan, pantoprazole/ protonix) were consistently below the limit of 336 detection. 337
338
LC-HRMS based screening and confirmation of suspects 339
In Figure 2 , the reduction of candidate masses in the different prioritization steps of 340 the suspect screening workflow is shown. Prioritization according to frequency of 341 detection and intensity of peaks in individual samples yielded the largest reduction in 342 candidate masses, i.e., to about 50% of the 559 individual mass hits from the extracted 343 ion chromatograms. About 100 candidate masses each were further deselected due to 344 either their presence in method blank samples or unsatisfactory peak symmetry to 345 yield 77 remaining candidate masses. Only about 50% of these showed isotope 346 patterns that were in agreement with simulations for the molecular formula of the 347 corresponding API suspect. Prioritization thus yielded a final list of 36 candidate 348 masses, of which two were detected in both positive and negative ionization mode 349 (Table S4 ). All candidate substances were subjected to confirmatory analysis with 350 purchased authentic reference standards. 351
Of the 36 priority suspects, 26 substances could be confirmed with reference 352 standards according to the criteria given in the methods section. The confirmed 353 suspects are given in Table 2 along with their precursor ion mass, retention time, the 354 two most abundant fragment ions and occurrence in WWTP samples. Concentrations 355 of the confirmed suspects were quantified as indicated in the method section and are 356 also given in Table 2 . 357 Altogether, the 26 APIs newly identified by exact mass screening amount to 22% 364 relative to the 119 parent APIs that were already on the target list, which we had 365 continuously updated based on available use data and information from monitoring 366 studies in other countries. When put in relation to those 85 target APIs that were 367 actually detected in one or several of the WWTP samples, our procedure increased the 368 number of detected APIs almost by one third. The study thus significantly adds to the 369 number of compounds known to be present in WWTP effluents, while demonstrating 370 the potential of LC-HRMS-based suspect screening workflows to efficiently reduce 371 the number to those suspects likely to be present in the sample(s). Here, nearly three 372 quarters of these could be confirmed by authentic reference standards, indicating a 373 high selectivity of the procedure, i.e., only 10 of the 36 priority suspects (28%) were 374 false positives. Those findings are in good agreement with the number of false 375 positive detects for pesticides in surface waters using a comparable suspect screening 376 confirmed suspect APIs were almost ubiquitous in the analyzed WWTP effluents, at 386 least amongst WWTPs A-E, three confirmed suspects were only abundant in one 387 effluent sample (Table 2 ). Of these, midazolam and oxybutynin are known to be 388 extensively metabolized with only 1 % of the parent API typically being excreted 48 , 389 and ticlopidine had even been removed from the Swiss market since about 1999. 390
These findings suggest that the substances originate from manufacturing or 391 formulation sites within the WWTP catchment rather than from unusual domestic 392 consumption, thus indicating the potential of LC-HRMS-based suspect screening to 393 capture instances of APIs stemming from point sources rather than regular 394
consumption. 395
It is further worth noting that altogether seven of the confirmed suspects were also 396 listed by Howard and Muir 26 on their lists of potential hazard priority APIs that had 397 not been detected in the environment before (marked in Table 2 ). Although our 398 screening procedure is targeted at APIs with high exposure potential in surface 399 waters, i.e., rather persistent and polar HPV substances such as chlorthalidone, it 400 nevertheless picked up some of the potentially also bioaccumulative ones (i.e., 401 fexofenadine, flecainide, flufenamic acid, lorazepam, midazolam, ticlopidine). When 402 comparing our remaining confirmed suspects that were not listed by Howard and 403 Muir 26 against their persistence and bioaccumulation cut-off criteria, we found that 404 13 more of them qualify as persistent but not bioaccumulative (marked in Table 2 ). 
Exposure prediction -Performance and additional suspects 425
In Figure 3 , predicted effluent concentrations are compared to measured 426 concentrations (minimal, median, maximal) in WWTPs A-E for 88 target APIs. For 427 the remaining 31 target APIs (marked in Table S3) (minimal, median, maximal) We therefore applied the model predictions to identify further APIs with high 452 exposure potential from the list of all 1022 suspect APIs that had not been part of the 453 target list nor had been captured by the suspect screening approach. To limit the 454 number of false positives, the subset of substances explored was restricted to those 455 expected to be present in high concentrations (PEC > 1 µg/L). Altogether, the model 456 predicted 44 substances to be present in concentrations > 1 µg/L. Of these, 15 457 substances were already on the list of target compounds (marked in Table S3 ). (Table S5 ) that had not been on the target list nor had they been 463 identified during suspect screening. For these, LC-HRMS spectra were re-inspected 464 with less stringent criteria to search for positive detects at their exact masses in 465 samples from WWTPs A-F. For only four substances, HR-MS peaks were found in 466 one or several of the samples that were not present in the blanks and for which isotope 467 patterns were consistent with the molecular formula. For these, analytical reference 468 standards were purchased, but only one substance, the antihypertension drug aliskiren, 469 could be confirmed (Table 2) . One more substance (ioversol) was considered likely to 470 be present, but due to a low intensity MSMS spectrum it could not definitely be 471 confirmed (Table S5 ). The remaining two candidate substances were rejected based 472 on the evidence from the reference standards. For aliskiren, re-inspection of the HR-473 MS workflow data indicated that it had been excluded (within the broad tolerance 474 window of ±1min for blank peak elimination) due to the presence of a peak with the 475 same accurate mass and a very similar retention time in the method blank. 476
For the remaining 25 out of 29 high-exposure suspects from exposure modeling, no 477 reasonable analytical signals could be detected. Upon inspection of the structures, two 478 major explanations were found (Table S5) Overall, the analytical suspect screening approach presented here allowed for a rapid 500 and cost-effective screening of wastewater treatment plant effluents for APIs with 501 significant exposure potential. It afforded the sensitive detection of 26 APIs that had 502 not been detected in Swiss surface waters before, thus increasing the number of 503 detected APIs by one third, while demonstrating a high selectivity of ≥ 70%. It also 504 captured substances that were likely to stem from point sources, which would not 505 emerge as priority substances from any of the previously used model-based 506 prioritization approaches. However, contrasting its high selectivity, there is ample 507 scope to produce false negatives with analytical suspect screening as discussed in the 508 introduction already. We therefore complemented it with model-based prioritization 509 based on consumption data, readily predictable fate properties and a generic mass 510 balance model for activated sludge treatment. 511
While prediction of substances with high exposure potential (PEC > 1 µg/L) 512 ultimately led to the identification of one additional compound only (aliskiren), it did 513 highlight eleven more compounds with potentially high exposure which either had 514 likely escaped the window of our analytical method, or for which model and HRMS-515 based approaches were in contradiction and that should therefore be prioritized for 516 further investigation. While we did not follow-up on these within the scope of this 517 study, they would add considerably to the 26 confirmed suspects in this study if their 518 presence was confirmed with complementary measurements and analytical methods. 519
At least for the three fluoroquinolones (i.e., ciprofloxacin, norfloxacin, and 520 levofloxacin), their presence in the aquatic environment has already been reported 521 (e.g., 54, 55 ) . 522
Interestingly, model-based prioritization with a selection cut-off of PEC > 1 µg/L did 523 not point out any of the substances identified by analytical suspect screening, the 524 majority of which had PEC values in the range of 10-100 ng/L. If the selection cut-off 525 for the PEC had been set to 10 ng/L to capture the majority of them, about 500 out of 526 the 1022 suspects had been on that priority list. Given the selectivity of ≤ 60% for 527 exposure-based prioritization estimated above, this would mean that HRMS spectra 528 would have to be re-inspected for 500 substances, of which at least 200 would be false 529 positives, leading to a prohibitively large effort. 530
In conclusion, we concur with Diamond et al. 25 that it is more accurate and efficient 531 to base a prioritization framework for APIs on measured occurrence rather than on 532 modeled exposure concentrations. However, rather than relying on occurrence data 533 for a few, easily amenable target compounds, such occurrence data should be 534 produced through comprehensive suspect screening as demonstrated in this study. 535
While exposure modeling seems too insensitive to efficiently predict which 536 substances should be included as targets in analytical methods for water quality 537 monitoring, our results indicate that exposure modeling can be a useful complement 538 to analytical suspect screening to identify substances with high exposure potential that 539 might either escape the detection window of the analytical method used or that had 540 been falsely removed during suspect screening. 541
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